Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects

Status Completed

Clinical Trial Summary

Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.

Clinical Trial Description

The purpose of this research is to learn about how the gastrointestinal bacteria (microbiome) can contribute to colon cancer, and how it may change due to colon cancer. In addition, we are going to study the features of the microbiome that can help predict recovery after colon resection. To do this, we are going to compare the microbiome from subjects with colon cancer to subjects without colon cancer. Study participation involves collection of stool samples before and after your surgery, as well as samples of residual (left-over) colon tissue from your surgery. We would also like to collect optional samples from your follow-up colonoscopy. You may be in the study for up to 5 years. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03951792
Study type	Observational
Source	Mayo Clinic
Contact
Status	Completed
Phase
Start date	May 28, 2019
Completion date	March 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03566160` - Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy	N/A
Active, not recruiting	`NCT05053191` - Advancing Nursing Practices in Hospital Oncology Care	N/A
Recruiting	`NCT03602677` - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage	N/A
Recruiting	`NCT04138225` - The Ecological Role of Yeasts in the Human Gut
Completed	`NCT00671177` - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique	N/A
Completed	`NCT00910104` - Cholestasis Reversal: Efficacy of IV Fish Oil	Phase 2/Phase 3
Recruiting	`NCT06236594` - Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases
Completed	`NCT05409196` - Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults	Phase 1
Enrolling by invitation	`NCT04719117` - Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
Recruiting	`NCT03719209` - Using Virtual Reality for Patients With Gastrointestinal Disease	N/A
Enrolling by invitation	`NCT03319446` - Collection of Anonymized Samples	N/A
Enrolling by invitation	`NCT03234543` - Remote Ischemic Conditioning in Abdominal Surgery	N/A
Completed	`NCT04498208` - Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery	N/A
Completed	`NCT03549494` - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction	Phase 2
Completed	`NCT03559543` - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma	Phase 2
Completed	`NCT03723447` - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)	Phase 4
Not yet recruiting	`NCT04514042` - Comparison of Zenker's Diverticulum Treatment Using Peroral Endoscopic Myotomy and Flexible Endoscopy Septotomy.	N/A
Suspended	`NCT04519086` - The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30	N/A
Completed	`NCT03019042` - Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Non-organic Gastrointestinal Disorders	N/A
Completed	`NCT05008640` - Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™